informaconnect.com Open in urlscan Pro
151.101.66.217  Public Scan

Form analysis
0 forms found in the DOM

Text Content

You need to enable JavaScript to run this app.
This website uses cookies, including third party ones, to allow for analysis of
how people use our website in order to improve your experience and our services.
By continuing to use our website, you agree to the use of such cookies. Click
here for more information on our Cookie Policy and Privacy Policy.
closeContinue


This site is part of the Informa Connect Division of Informa PLC

 * Informa PLC
 * About Us
 * Investor relations
 * Talent

This site is operated by a business or businesses owned by Informa PLC and all
copyright resides with them. Informa PLC's registered office is 5 Howick Place,
London SW1P 1WG. Registered in England and Wales. Number 3099067.


Delivered as a Hybrid Event May 23 - June 2, 2022
In-Person: May 23-25 ● Virtual: June 1-2Sheraton Philadelphia Downtown,
Philadelphia, PA
   Homehome
 * What's On? Agenda
 * Our Speakers
 * Pricing & Venue
 * Sponsors & Exhibitors
 * Enquiries & Customer Services
 * Delivering a Safe Live Event
 * The Virtual Experience
 * Event Sustainability

Register Now
Menu
Book
Delivered as a Hybrid Event May 23 - June 2, 2022
In-Person: May 23-25 ● Virtual: June 1-2Sheraton Philadelphia Downtown,
Philadelphia, PA



SPEAKERS

search
Streams
General Session
Industry In-Depth A: Unit of Measurement and Understanding NDC Numbers
Industry In-Depth B: Value-Based Frameworks and Government Pricing
Considerations
Industry In-Depth C: A Date with GP
Learning Stream 1: State Drug Price Transparency & Reporting
Learning Stream 2: Finance and Compliance Operations
Learning Stream 3: Strategies for Operationalizing 340B and Innovative Product
Contracts
Session A: 340B Reform
Session B: Best Price Rule
Session D: 340B Operational Strategies
Session E: Co-Pay Cards and Deductible Assistance
Session F: Medicaid AMP Removal
Summit 1
Summit 2
Summit 3
Summit 4

Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide


keyboard_arrow_leftSearch & Filter
search
Streams
General Session
Industry In-Depth A: Unit of Measurement and Understanding NDC Numbers
Industry In-Depth B: Value-Based Frameworks and Government Pricing
Considerations
Industry In-Depth C: A Date with GP
Learning Stream 1: State Drug Price Transparency & Reporting
Learning Stream 2: Finance and Compliance Operations
Learning Stream 3: Strategies for Operationalizing 340B and Innovative Product
Contracts
Session A: 340B Reform
Session B: Best Price Rule
Session D: 340B Operational Strategies
Session E: Co-Pay Cards and Deductible Assistance
Session F: Medicaid AMP Removal
Summit 1
Summit 2
Summit 3
Summit 4

Jeff Baab

Vice President, Advisory Services

IntegriChain

Mike Benedict

Senior Vice President, Pharmacy Operations

Apexus

Ruth Blatt, Pharmacist

Division of Pharmacy, Disabled and Elderly Health Programs Group

Centers for Medicare & Medicaid Services (CMS) - (invited)

Andrew Bressler, CFA

Managing Director, Global Research

Bank of America Merrill Lynch

Ryan Bruce

Associate Director - Disputes and Recovery

AstraZeneca

Lynn Buhl

Senior Director

Riparian

Cathy Burton-Meza

Associate Director, Government Rebates

Gilead

Rebecca Chan, MBA, CPA

Head of Managed Markets Operations, Pricing & Analytics

Vertex Pharmaceuticals

Katherine Chaurette

Senior Vice President, Healthcare Law and Compliance

Blueprint Medicines Corporation

Michael Collins

Drug Rebate Project Advisor

Gainwell Technologies

John Coster, PhD, RPh

Director, Division of Pharmacy, Center for Medicaid & CHIP Services

CMS (invited)

Meena Datta

Partner

Sidley Austin LLP

Louis Day

Social Science Research Analyst, Office of Evaluation and Inspections

Office of Inspector General (OIG)

Rujul Desai

Of Counsel

Covington & Burling LLP

Nicolette Dione, PharmD

Drug Rebate Services Manager

Gainwell Technologies

Susan Dunne

Senior Director

Riparian

Jennifer English

Head - Pricing, Contracting, New Products, Licensing and Acquisitions

Ipsen

Robert Fiore, MBA

Snr Mgr Business Development & Contract Analytics, National Accounts & Medicaid,
US Market Access,

GlaxoSmithKline

Tony George

Associate Director, Professional Services

Model N

Al Godley

Vice President, Customer Solutions

ClassOne Insight

Margaux Hall

Partner

Ropes & Gray LLP

Josephine Hawkins

Associate Director, Medicaid

AstraZeneca

Jodi Hettinga

Drug Rebate Manager

Gainwell Technologies

Scott Hoffman

Head of Client Services

Woven Data

Marcy Imada

Managing Director, Deloitte Advisory

Deloitte & Touche LLP

Dhirendra Jena

Senior Director, Professional Services

Model N

Scott Johnsen

VP of Product Design

Kalderos

Dena Karels, CPhT

Lead, Rebate Dispute Management

Magellan Health

Ted Karnezis

Owner

Karnezis Consulting

Karl Kemmerer

Director, Revenue, Supply Finance & Corporate Accounting

Eisai Inc.

Stephanie Kupski

Director, U.S. Pricing & Government Reporting

CSL Behring

Michael Kurland

Vice President, Revenue Management & Compliance

EVERSANA

Miree Lee, MS, MBA

Bio/Pharma Pricing, Contracts & Compliance Consultant

M.Lee Consulting LLC

Jeanine Lundeberg

Director, Pharmacy Rebate Management

Magellan Health

Greg Madden

Managing Member

Orlaithe Consulting

Felecia Manning

Director, Managed Markets Contracts & Government Pricing

United Therapeutics Corporation

Paula C. Martins

Director, Government Pricing & Contract Operations

Eisai US

Brian McCartney

Senior Director, Market Access Policy & Government Reporting

AstraZeneca

John McGrory

CEO

ClassOne Insight

Tess Morgan

Senior Manager, Product Diversion and Program Integrity

Pfizer

DC Moxey

Legal Director

AstraZeneca

Heather Murphy

Senior Operations Analyst

IntegriChain

Oonagh O'Malley

Associate Director, Government Pricing & Reporting

Insmed Incorporated

Christine Ostrowski

Head of Pricing

Purdue Pharma, LP

Jennifer Plitsch

Partner

Covington & Burling LLP

Dorine Rascoe

Division Chief, Drug Rebates and Lockbox Services, Office of Finance, Medical
Care Programs

Maryland Department of Health

William Sarraille

Partner

Sidley Austin LLP

Mark Scallon

Principal

Baker Tilly US, LLP

Linda Schock

Executive Director, Channel Operations & Government Reporting

Coherus BioSciences

Christopher Schott

Partner

Latham & Watkins LLP

Tyler Seville

Associate Director, Public Policy

Novartis

John Shakow

Partner

King & Spalding

David Tawes

Regional Inspector General, Office of Evaluation and Inspections

Office of Inspector General (OIG)

Stephanie Trunk

Partner

Arent Fox

Alice Valder Curran

Partner

Hogan Lovells

Aaron Vandervelde

Managing Director

BRG

Trevor Wear

Partner

Sidley Austin LLP

Constance Wilkinson

Board of Directors and Member of the Firm

Epstein Becker Green

Clay Willis

Director

BRG

Cathy Zhang

Director, Government Reporting and Pricing Compliance

SK Life Science, Inc.

Filter
Streams
General Session
Industry In-Depth A: Unit of Measurement and Understanding NDC Numbers
Industry In-Depth B: Value-Based Frameworks and Government Pricing
Considerations
Industry In-Depth C: A Date with GP
Learning Stream 1: State Drug Price Transparency & Reporting
Learning Stream 2: Finance and Compliance Operations
Learning Stream 3: Strategies for Operationalizing 340B and Innovative Product
Contracts
Session A: 340B Reform
Session B: Best Price Rule
Session D: 340B Operational Strategies
Session E: Co-Pay Cards and Deductible Assistance
Session F: Medicaid AMP Removal
Summit 1
Summit 2
Summit 3
Summit 4


 * Home
 * Contact
 * Privacy
 * Terms of Use
 * Terms & Conditions
 * CCPA: Do not sell my personal info


×
×

×
We Value Your Privacy
Settings
NextRoll, Inc. ("NextRoll") and our advertising partners use cookies and similar
technologies on this site and use personal data (e.g., your IP address). If you
consent, the cookies, device identifiers, or other information can be stored or
accessed on your device for the purposes described below. You can click "Allow
All" or "Decline All" or click Settings above to customize your consent.
NextRoll and our advertising partners process personal data to: ● Store and/or
access information on a device; ● Create a personalized content profile; ●
Select personalised content; ● Personalized ads, ad measurement and audience
insights; ● Product development. For some of the purposes above, our advertising
partners: ● Use precise geolocation data. Some of our partners rely on their
legitimate business interests to process personal data. View our advertising
partners if you wish to provide or deny consent for specific partners, review
the purposes each partner believes they have a legitimate interest for, and
object to such processing.
If you select Decline All, you will still be able to view content on this site
and you will still receive advertising, but the advertising will not be tailored
for you. You may change your setting whenever you see the Manage consent
preferences on this site.
Decline All
Allow All
Manage consent preferences